Listed

Belite Bio, Inc

BLTENasdaqCIK 1889109HealthcareFiscal year ends Dec 31

Reports and events: 61 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Belite Bio, Inc, Reports and events
FiledFormWhat it isAccession number
2023-04-0320:14 ET6-KReport of a foreign private issuerPeriod 2023-03-310001104659-23-040395
2023-03-3116:02 ET20-FAnnual report of a foreign private issuerPeriod 2022-12-310001104659-23-040145
2022-12-1316:01 ET6-KReport of a foreign private issuerPeriod 2022-12-130001104659-22-126599
2022-11-1808:00 ET6-KReport of a foreign private issuerPeriod 2022-11-180001104659-22-120070
2022-10-0306:02 ET6-KReport of a foreign private issuerPeriod 2022-10-010001104659-22-104829
2022-09-1608:06 ET6-KReport of a foreign private issuerPeriod 2022-09-160001104659-22-100641
2022-08-2208:00 ET6-KReport of a foreign private issuerPeriod 2022-08-220001104659-22-093109
2022-08-1121:48 ET6-KReport of a foreign private issuerPeriod 2022-08-100001104659-22-088899
2022-07-1916:05 ET6-KReport of a foreign private issuerPeriod 2022-07-190001104659-22-080840
2022-05-1216:34 ET6-KReport of a foreign private issuerPeriod 2022-05-120001104659-22-059486
2022-05-0307:04 ET6-KReport of a foreign private issuerPeriod 2022-05-310001104659-22-055003

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:16 ET. Listed shows no prices and gives no investment advice.